Carmen Z Michaylira

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice
    Carmen Z Michaylira
    Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, 27599 7545, USA
    Endocrinology 147:1632-41. 2006
  2. ncbi Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation
    Megan E Miller
    Department of Nutrition, University of North Carolina at Chapel Hill, 27599 7545, USA
    Gastroenterology 127:570-81. 2004
  3. ncbi Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells
    Shira Fruchtman
    Dept of Cell and Molecular Physiology, CB 7545, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7545, USA
    Am J Physiol Gastrointest Liver Physiol 289:G342-50. 2005
  4. ncbi Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo
    Carmen Z Michaylira
    CB 7545, Dept of Cell and Molecular Physiology, Univ of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7545, USA
    Am J Physiol Gastrointest Liver Physiol 291:G472-81. 2006
  5. pmc IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms
    Munenori Takaoka
    Gastroengerology Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 6:534-40. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice
    Carmen Z Michaylira
    Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, 27599 7545, USA
    Endocrinology 147:1632-41. 2006
    ..Small variations in SOCS2 expression levels may significantly influence the outcome of therapeutic GH or acromegaly in intestine...
  2. ncbi Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation
    Megan E Miller
    Department of Nutrition, University of North Carolina at Chapel Hill, 27599 7545, USA
    Gastroenterology 127:570-81. 2004
    ..These studies test the hypothesis that GH induces a suppressor of cytokine signaling (SOCS), which inhibits intestinal epithelial cell (IEC) proliferation...
  3. ncbi Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells
    Shira Fruchtman
    Dept of Cell and Molecular Physiology, CB 7545, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7545, USA
    Am J Physiol Gastrointest Liver Physiol 289:G342-50. 2005
    ....
  4. ncbi Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo
    Carmen Z Michaylira
    CB 7545, Dept of Cell and Molecular Physiology, Univ of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7545, USA
    Am J Physiol Gastrointest Liver Physiol 291:G472-81. 2006
    ..We conclude that SOCS2 normally limits basal and IGF-I- and EGF-induced intestinal growth in vivo and has novel inhibitory effects on the IGF-IR tyrosine kinase pathway in intestinal epithelial cells...
  5. pmc IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms
    Munenori Takaoka
    Gastroengerology Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 6:534-40. 2007
    ..In aggregate, these data suggest that IGFBP-3 contributes to esophageal tumor development and progression through IGF-dependent and independent mechanisms...